Immunome (IMNM) Retained Earnings (2019 - 2026)
Immunome (IMNM) reported Retained Earnings of -$782.0 million for Q1 2026, down 26066566.67% on a YoY basis from N/an in Q1 2025, and down 7.39% quarter-over-quarter from -$728.2 million in Q4 2025.
Immunome (IMNM) Retained Earnings (2019 - 2026) Analysis & Trends
Immunome has reported Retained Earnings for 8 years, with the latest figure at -$782.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 26066566.67% year-over-year to -$782.0 million; the trailing twelve-month figure through Mar 2026 stood at -$782.0 million (down 26066566.67% YoY), and the FY2025 full-year result was -$728.2 million, down 41.18% from the prior year.
- Retained Earnings for Q1 2026 stood at -$782.0 million, down from -$728.2 million in the prior quarter.
- The five-year high for Retained Earnings was $22000.0 in Q4 2023, with the low at -$782.0 million in Q1 2026.
- Historically, Retained Earnings has averaged -$287.1 million across 5 years, with a median of -$128.0 million in 2023.
- Annual changes were most pronounced in 2023 — Retained Earnings soared 100.02% — and 2026, when it sank 26066566.67%.
- Immunome's Retained Earnings stood at -$116.0 million in 2022, then jumped by 100.02% to $22000.0 in 2023, then tumbled by 2344509.09% to -$515.8 million in 2024, then slumped by 41.18% to -$728.2 million in 2025, then slipped by 7.39% to -$782.0 million in 2026.
- The last three Retained Earnings figures came in at -$782.0 million (Q1 2026), -$728.2 million (Q4 2025), and -$600.8 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 130.89 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -279.00 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -838.07 Mn |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | -782.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -782.00 Mn |
| Dec 31, 2025 | -728.16 Mn |
| Jun 30, 2025 | -600.81 Mn |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | -515.77 Mn |
| Sep 30, 2024 | -435.52 Mn |
| Jun 30, 2024 | -388.40 Mn |
| Mar 31, 2024 | -352.30 Mn |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | -130.20 Mn |
| Jun 30, 2023 | -125.80 Mn |
| Mar 31, 2023 | -120.30 Mn |
| Dec 31, 2022 | -116.00 Mn |
| Sep 30, 2022 | -108.20 Mn |
| Jun 30, 2022 | -99.70 Mn |
| Mar 31, 2022 | -90.76 Mn |
| Dec 31, 2021 | -79.11 Mn |
| Sep 30, 2021 | -71.25 Mn |
| Jun 30, 2021 | -63.50 Mn |
| Mar 31, 2021 | -58.30 Mn |